Analysis and trackers
Deep Dive
Longer reads on the forces moving the industry, and running trackers we keep up to date as deals close and data arrives.
TrackerCross-border deals
Drugs discovered in China are reshaping dealmaking. Track the licensing agreements here.
Updated Sept. 29, 2026Deals
TrackerIPO window
Biotech IPOs are the sector's lifeblood. Here is how this year's class is performing.
Updated Sept. 25, 2026Biotech
Deep Dive
Biotech acquisitions are accelerating. Follow the deals as they happen.
Updated Sept. 22, 2026Deals
The day in drug development, by 7 a.m.
One email each weekday with the stories our editors would send a colleague. Free, and you can leave whenever you like.
Deep DiveEmerging biotech
Biotech startups run on venture capital. Track this year's funding rounds.
Updated Sept. 14, 2026Biotech
TrackerPatent cliff
Patents protect pharma profits. Track when the biggest ones expire.
Updated Sept. 10, 2026Pharma